Gradient Therapeutics

Gradient Therapeutics

Gradient Therapeutics

Gradient is developing a novel transvascular, catheter based technology based on proven clinical, human data to treat pulmonary hypertension, a fatal condition that effects approximately 500,000 patients per year worldwide.
Follow us
Alexa global traffic share
Team Size
1–10
Employees

No recent coverage

Index constantly checks hot and trending companies for their latest activity. We haven't gotten to this company yet, but if you follow it you'll be the the first to know when Gradient Therapeutics makes some noise.